This document details a large-scale genomic analysis project conducted by Janssen R&D, focusing on correlating drug therapy responses in rheumatoid arthritis patients with genetic variants through whole-genome sequencing of 438 patients. The project involved advanced genomic analytics and utilized significant computational resources, including a 9-step read mapping and a subsequent variant calling pipeline, efficiently processing 50 TB of data within a tight timeline. Key challenges included data management and computing requirements, with innovative solutions like bigflash implemented to enhance performance.